Maximum Radiation Exposure to Bystanders in Nuclear Medicine
Radioiodine-131 (¹³¹I) therapy for thyroid cancer and other therapeutic nuclear medicine procedures expose bystanders to the highest radiation doses, with therapeutic ¹³¹I activities of 100 mCi (3.7 GBq) or more creating significantly greater exposure risk than any diagnostic procedure.
Therapeutic vs Diagnostic Procedures
The distinction between therapeutic and diagnostic nuclear medicine is critical when considering bystander exposure:
Therapeutic Procedures (Highest Exposure)
- ¹³¹I therapy uses activities of 100 mCi (3.7 GBq) or higher for treating thyroid cancer, with patients remaining radioactive for days 1
- ⁹⁰Y-labeled therapies (radiosynovectomy, peptide receptor radionuclide therapy) expose staff to whole-body doses of 146 µSv and finger doses up to 14.6 mSv over 12 months 2
- ¹⁸⁹Sm-EDTMP for bone metastases similarly creates prolonged exposure periods 2
The key differentiator is the activity administered: therapeutic procedures use 10-100 times higher activities than diagnostic studies, and the longer physical half-lives (¹³¹I = 8 days) mean patients remain radioactive sources for extended periods.
Diagnostic Procedures (Lower Exposure)
Diagnostic procedures produce substantially lower bystander exposure:
- ¹⁸F-FDG PET/CT: Maximum dose rate 780 µSv/h immediately post-injection (370 MBq), dropping to one-third within 2 hours 3
- ⁹⁹ᵐTc procedures: Maximum 250 µSv/h (700 MBq), rapidly decreasing due to 6-hour half-life 3
- ¹²³I studies: 132 µSv/h (370 MBq) 3
- ¹¹¹In-octreotide: 150 µSv/h (185 MBq) 3
At 0.5 meters distance, these values decrease by an order of magnitude 3.
Why Therapeutic ¹³¹I Poses Maximum Risk
The combination of factors makes therapeutic ¹³¹I the highest bystander exposure scenario:
- High administered activity: 100+ mCi vs 1-5 mCi for diagnostic studies
- Long physical half-life: 8 days vs hours for most diagnostic isotopes
- Gamma emission: 364 keV photons penetrate tissue and shielding
- Prolonged patient contact: Family members and caregivers have extended exposure over days
- Outpatient treatment: Unlike some therapies, many ¹³¹I patients are discharged home
Practical Exposure Levels
For context on actual bystander doses:
- Companions in nuclear medicine departments receive maximum doses well below regulatory limits 4
- Staff performing diagnostic procedures receive 0.3-1.6 µSv per patient procedure 5, 6
- However, therapeutic procedures require specific radiation safety protocols including patient isolation and restricted contact with pregnant women and children 1
Critical Caveat
While ¹³¹I therapy creates the highest bystander exposure potential, interventional radiology procedures (though not strictly "nuclear medicine") can expose staff to higher cumulative doses due to prolonged fluoroscopy times, with whole-body effective doses of 12.6 µSv per procedure for operators 7. However, these are X-ray based, not radiopharmaceutical-based exposures.
The effective dose from FDG PET/CT ranges from 1-20+ mSv depending on CT protocol 8, but this is patient dose, not bystander exposure. The distinction between patient dose and bystander/staff dose is essential—therapeutic nuclear medicine procedures create the highest bystander exposure risk due to the patient becoming a mobile radiation source for extended periods.